News
FDA OKs Merck Co Inc s Janumet XR for Type 2
WHITEHOUSE STATION, N.J.---- Merck , known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration
Osteopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 | PRLog
Osteopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2019. Osteopenia Therapeutics Market Forecast to Show Moderate Growth up to 2019 - PR11788332
Pfizer recalls 1m packets of birth control pills - FT.com
Pfizer, the world’s largest drug maker by revenues, has recalled 1m packets of birth control pills after finding that faulty packaging could potentially lead to unwanted pregnancies. “As a result of this packaging error, the daily regimen for these
National Study Shows Weight-Loss Surgery Frees Most Obese Type 2 Diabetics of Insulin and Other
Results of a large national study show that nearly three-quarters of obese patients with type 2 diabetes who undergo weight-loss surgery are able to stop insulin and other antidiabetes drugs within six months.
Warner Chilcott CEO Discusses 2012 Guidance (Transcript) - Seeking Alpha
< p > Warner Chilcott plc ( < a href='http://seekingalpha.com/symbol/wcrx' title='Warner Chilcott Limited' > WCRX < /a > ) < /p > < p > 2012 Guidance Call < /p > < p > January 27, 2012 8:00 AM ET < /p > < p > < strong > Executives < /strong > < /p > < p > Paul Herendeen – EVP & amp; CFO < /p > < p
European Commission Adopts European Medicines Agency’s Opinion Confirming Pioglitazone-Containing
Osaka, Japan and London, United Kingdom, 10<sup>th</sup> January 2012 -- Takeda Pharmaceutical Company Limited (“Takeda”) announced today that the European Commission (EC) has adopted the European Medicines Agency (EMA)’s Committee for Medical Products for Human Use (CHMP) opinion as recommended in
Oral contraceptive benefit confirmed for dysmenorrhoea | 6minutes
Oral contraceptive use is associated with a reduced severity of dysmenorrhoea, but newer contraceptives may have less impact, a Scandinavian study suggests.
Intrauterine device and cervical cancer: we need more evidence – Authors' reply : The Lancet
Intrauterine device and cervical cancer: we need more evidence – Authors' reply. By - Xavier Castellsagué, Mireia Díaz, Salvatore Vaccarella, Silvia de Sanjosé, Nubia Muñoz, Rolando Herrero, Silvia...
Study Revealing Food Additives Increase Risk of Diabetes Supported by Doctors Health Press
The Doctors Health Press, a publisher of various natural health newsletters books and reports, including the popular online Doctors Health Press e-Bulletin, supports a recent clinical study that found a common food additive, carrageenan, could lead to glucose intolerance and insulin resistance.
Biomarkers Consortium, FNIH, ICON, variability in insulin secretory parameters | Biomarkers
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced it has received a contract award from the Foundation for the National Institutes of Health (FNIH) to provide clinical support for the Biomarkers Consortium study
Refine by Topic:
- Blood Sugar Regulating Drugs (2,616)
- Calcium-regulating Drugs (140)
- Corticosteroids (199)
- Hypothalamus Hormones (136)
- Pituitary Hormones (41)
- Sex Hormones & Oral Contraceptives (424)
Refine by Content Type:
Refine by Source:
- www.thelancet.com (1,198)
- diabetes.webmd.com (641)
- www.em-consulte.com (501)
- download.thelancet.com (257)
- www.prlog.org (154)
- www.medpagetoday.com (138)
- www.australiandoctor.com.au (69)
- www.biospace.com (65)
- www.6minutes.com.au (64)
- www.prweb.com (62)
- www.aerzteblatt.de (45)
- www.medport.de (42)
